Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
대표청구항▼
1. A system for inflating an intragastric balloon, the system comprising: an inflation catheter, wherein the inflation catheter comprises a needle assembly comprising a hollow needle and a bell-shaped needle sleeve;an intragastric balloon comprising a balloon valve system comprising a self-sealing s
1. A system for inflating an intragastric balloon, the system comprising: an inflation catheter, wherein the inflation catheter comprises a needle assembly comprising a hollow needle and a bell-shaped needle sleeve;an intragastric balloon comprising a balloon valve system comprising a self-sealing septum in a retaining structure, wherein the self-sealing septum is configured for piercing by the hollow needle, wherein the retaining structure comprises a concentric valve system with a smaller inner cylinder housing the self-sealing septum and a larger outer cylinder housing a material providing compressive forces against the bell-shaped needle sleeve of the inflation catheter for inflation and detachment, wherein the smaller inner cylinder comprises a lip configured for an interference fit with the bell-shaped needle sleeve to provide sealing of the balloon valve system to the inflation catheter sufficient to maintain a seal during inflation of the intragastric balloon, wherein the interference fit is configured to provide detachment of the inflation catheter from the intragastric balloon after inflation of the balloon in vivo is complete, wherein the outer cylinder comprises a head unit comprising a circular lip that is larger than a diameter of the inner cylinder and extends to an outside surface of the intragastric balloon, wherein the circular lip of the head unit is configured for an interference fit with the bell-shaped needle sleeve;a balloon outer container; andan inflation source container, wherein the inflation source container is configured to connect to the inflation catheter;wherein the inflation catheter connected to the intragastric balloon prior to inflation is of a size and shape configured for swallowing by a patient in need thereof. 2. The system of claim 1, wherein the intragastric balloon comprises a polymeric wall comprising a barrier material comprising a layer of nylon and a layer of polyethylene. 3. The system of claim 1, wherein the intragastric balloon comprises a polymeric wall comprising a barrier material comprising a layer of nylon, a layer of polyvinylidene chloride, and a layer of polyethylene. 4. The system of claim 1, wherein the balloon outer container is selected from the group consisting of a push-fit capsule, a wrap, and a band, and wherein the balloon outer container comprises a material selected from the group consisting of gelatin, cellulose, and collagen. 5. The system of claim 1, wherein the self-sealing septum is cone-shaped. 6. The system of claim 1, wherein the inflation source container is configured to connect to the inflation catheter via a connector or an inflation valve. 7. The system of claim 1, wherein the inflation catheter is from 1 French to 6 French in diameter, and is from about 50 cm to about 60 cm in length. 8. The system of claim 1, wherein the inflation catheter is a dual lumen catheter comprising an inflation lumen and a detachment lumen, wherein the inflation lumen is in fluid connection to the inflation source container, and wherein the detachment lumen is configured for connection to a detachment liquid source container containing a detachment liquid, wherein the detachment liquid comprises a physiological compatible liquid, and wherein the interference fit is insufficient to maintain the seal upon application of a hydraulic pressure by the detachment liquid, such that upon application of the hydraulic pressure to the needle assembly it is ejected from the balloon valve system. 9. The system of claim 1, wherein the inflation catheter comprises a single lumen and a structural member providing increased tensile strength, and an inflation valve configured for connecting the single lumen to the inflation source container and a detachment liquid source container containing detachment liquid, wherein the detachment liquid comprises a physiological compatible liquid, and wherein the interference fit is insufficient to maintain the seal upon application of a hydraulic pressure by the detachment liquid, such that upon application of the hydraulic pressure to the needle assembly it is ejected from the balloon valve system. 10. The system of claim 1, wherein the inner cylinder is configured to control alignment of the needle assembly with the self-sealing septum, provide a barrier to the hollow needle piercing the polymeric wall, and provide compression such that the self-sealing septum reseals after inflation and hollow needle withdrawal. 11. The system of claim 1, wherein a plurality of intragastric balloons are connected to the inflation catheter. 12. The system of claim 1, wherein the inflation catheter is of a variable stiffness. 13. The system of claim 1, wherein the inflation source container comprises a syringe. 14. The system of claim 1, wherein the inflation source container is configured to utilize information regarding inflation pressure as a function of time to provide feedback to a user, wherein the feedback indicates a condition selected from the group consisting of failure by mechanical blockage, failure by esophagus constraint, failure by inflation catheter leak or detachment, and successful intragastric balloon inflation. 15. The system of claim 1, further comprising an inflation fluid contained in the inflation source container. 16. The system of claim 15, wherein the inflation fluid is selected from the group consisting of nitrogen, oxygen, CO2, a single fluid, a single gas, and a mixture of gases. 17. The system of claim 15, wherein the inflation fluid comprises an inert gas. 18. The system of claim 15, wherein the inflation fluid comprises two inert gases, wherein one of the inert gases is more soluble than the other inert gas in a gastric environment. 19. The system of claim 15, wherein the inflation fluid comprises two inert gases, wherein one of the inert gases has a lower diffusivity through a polymeric wall of the balloon than the other inert gas. 20. The system of claim 1, wherein the head unit is silicone. 21. The system of claim 1, wherein the circular lip of the outer cylinder does not protrude more than 2 mm past the outside surface of the intragastric balloon. 22. The system of claim 1, wherein the circular lip of the outer cylinder is configured to provide compressive forces against the bell-shaped needle sleeve for inflation and detachment, such that the interference fit can withstand a pressure of 35 PSI during inflation. 23. The system of claim 22, wherein a seal of the connection coupling is configured to be broken during detachment using a hydraulic pressure that is more than 40 PSI but less than 200 PSI to separate the connection coupling. 24. A method for inflating an intragastric balloon, the method comprising: providing the system of claim 1;piercing the self-sealing septum by the hollow needle of the inflation catheter, whereby an interference fit is created between the bell-shaped needle sleeve and the lip of the smaller inner cylinder;causing the intragastric balloon in the balloon outer container attached by the interference fit to the inflation catheter to be swallowed by a patient in need thereof;degrading the outer container so as to permit inflation of the intragastric balloon;inflating the intragastric balloon with an inflation fluid in the patient's stomach via the inflation catheter, wherein the inflation catheter is connected to the inflation source container containing the inflation fluid; anddetaching the intragastric balloon from the inflation catheter, wherein a detachment liquid comprising a physiological compatible liquid is forced through the inflation catheter to apply hydraulic pressure to the needle assembly such that the interference fit between the lip and the bell-shaped needle sleeve is broken, the needle assembly is ejected from the balloon valve system and the self-sealing septum reseals. 25. The method of claim 24, wherein the inflation catheter is a dual lumen catheter comprising an inflation lumen and a detachment lumen, wherein the inflation lumen is configured for fluid connection to the inflation source container, and wherein the detachment lumen is configured for connection to a detachment liquid source container for detachment of the intragastric balloon. 26. The method of claim 24, wherein the inflation catheter is a single lumen catheter comprising a structural member providing increased tensile strength and an inflation valve configured for first connecting the single lumen catheter to the inflation source container and then to a detachment liquid source container for detachment of the intragastric balloon. 27. The method of claim 24, further comprising monitoring inflation pressure as a function of time and detaching when a predetermined ending pressure is obtained, wherein successful intragastric balloon inflation is indicated by achievement of the preselected ending pressure, which is based on a starting pressure in the inflation source and an inflation volume of the intragastric balloon. 28. The method of claim 24, wherein the inflation fluid is selected from the group consisting of nitrogen, oxygen, CO2, a single fluid, a single gas, and a mixture of gases. 29. The method of claim 24, wherein the inflation fluid comprises an inert gas. 30. The method of claim 24, wherein the inflation fluid comprises two inert gases, wherein one of the inert gases is more soluble than the other inert gas in a gastric environment. 31. The method of claim 24, wherein the inflation fluid comprises two inert gases, wherein one of the inert gases has a lower diffusivity through the polymeric wall than the other inert gas.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (55)
Kullas Karen E. (Taunton MA) Giusto Joseph (Warren RI), Anti-obesity balloon placement system.
Imran, Mir; Herrmann, Peter; Syed, Baber; Williams, Timothy H.; Ong, Chang Jin; Method, Greg, Device, system and methods for the oral delivery of therapeutic compounds.
Matsuura, David G.; Gillespie, Walter D.; Wallin, Sheila K.; Connors, Kevin G.; Bullister, Edward, Devices and methods for attenuation of pressure waves in the body.
Lewkowicz,Shlomo; Gat,Daniel; Glukhovsky,Arkady; Khait,Semion; Iddan,Gavriel Joseph; Jacob,Harold; Swain,Christopher Paul, Floatable in vivo sensing device and method for use.
Yamamoto Taizo (Osaka JPX) Abe Kenji (Nara JPX) Matsuura Seinosuke (Souraku JPX), Hard capsule for pharmaceutical drugs and method for producing the same.
Weiner Brian C. (24 Bowling Green Pl. Staten Island NY 10314) Weiner Sarah H. (24 Bowling Green Pl. Staten Island NY 10314), Inflatable gastric device for treating obesity and method of using the same.
Gau Fred C. (14812 Imperial Dr. Libertyville IL 60048) Hancock John C. (449 Paseo del Descanso Santa Barbara CA 93105), Intragastric balloon with improved valve locating means.
Brister, Mark C.; Quintana, Nelson; Patel, Kaushik A.; Drake, Neil R.; Llevares, Antonio C.; Markovic, Dubravka; Rasdal, Andrew P.; VandenBerg, Amy D. L., Intragastric device.
Brister, Mark C.; Quintana, Nelson; Patel, Kaushik A; Drake, Neil R.; Llevares, Antonio C.; Markovic, Dubravka; Rasdal, Andrew P.; VandenBerg, Amy D. L., Intragastric device.
Berman Edward J. (3426 N. Meridian Indianapolis IN 46208) Rowe George A. (3426 N. Meridian Indianapolis IN 46208), Method and apparatus for reducing obesity.
Smith Jeffrey A. ; Wallace Daniel T. ; Hlavka Edwin J. ; Gresl Charles ; Lunsford John P. ; Chin Albert K., Method and inflatable chamber apparatus for separating layers of tissue.
Kim Sunyong (105 Valley Forge St. Charles MO 63303) Lee Dae W. (1575 N. Warson Rd. St. Louis MO 63132), Self-contained, self-inflating novelty balloon.
Imran, Mir, Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device.
Imran, Mir, Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device.
Brister, Mark C.; Faucher, Paul D.; Drake, Neil R.; Rasdal, Andrew P.; Lake, Matthew S.; Markovic, Dubravka; VandenBerg, Amy D. L.; Llevares, Antonio C.; Nider, Josefina, Intragastric device.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.